SOFFREDINI, ROBERTA MARIA
 Distribuzione geografica
Continente #
NA - Nord America 2.057
AS - Asia 1.925
EU - Europa 1.871
Continente sconosciuto - Info sul continente non disponibili 203
SA - Sud America 157
AF - Africa 45
OC - Oceania 7
Totale 6.265
Nazione #
US - Stati Uniti d'America 1.933
CN - Cina 633
GB - Regno Unito 601
DE - Germania 454
SG - Singapore 452
IT - Italia 315
BD - Bangladesh 264
HK - Hong Kong 152
BR - Brasile 125
SE - Svezia 105
VN - Vietnam 105
RU - Federazione Russa 103
CA - Canada 76
IN - India 74
FR - Francia 65
NL - Olanda 55
JP - Giappone 52
TR - Turchia 43
FI - Finlandia 35
MX - Messico 35
IE - Irlanda 31
KR - Corea 30
ID - Indonesia 29
TW - Taiwan 28
DK - Danimarca 25
IQ - Iraq 20
UA - Ucraina 15
EG - Egitto 13
EU - Europa 12
ES - Italia 11
AR - Argentina 10
AT - Austria 10
CO - Colombia 8
CH - Svizzera 7
GR - Grecia 7
AU - Australia 6
BE - Belgio 6
CI - Costa d'Avorio 6
ZA - Sudafrica 6
DZ - Algeria 5
MM - Myanmar 5
PL - Polonia 5
TH - Thailandia 5
CL - Cile 4
CR - Costa Rica 4
PH - Filippine 4
SA - Arabia Saudita 4
IL - Israele 3
IR - Iran 3
JO - Giordania 3
KE - Kenya 3
PE - Perù 3
PK - Pakistan 3
RO - Romania 3
BG - Bulgaria 2
EC - Ecuador 2
ET - Etiopia 2
GT - Guatemala 2
HU - Ungheria 2
LT - Lituania 2
LU - Lussemburgo 2
LV - Lettonia 2
MY - Malesia 2
PY - Paraguay 2
UZ - Uzbekistan 2
VE - Venezuela 2
ZM - Zambia 2
AE - Emirati Arabi Uniti 1
BB - Barbados 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
EE - Estonia 1
GE - Georgia 1
GH - Ghana 1
GW - Guinea-Bissau 1
GY - Guiana 1
HN - Honduras 1
JM - Giamaica 1
KN - Saint Kitts e Nevis 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MA - Marocco 1
MD - Moldavia 1
MR - Mauritania 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PT - Portogallo 1
SC - Seychelles 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 6.073
Città #
Southend 515
Singapore 286
Ashburn 240
San Jose 145
Beijing 133
Hong Kong 132
Chandler 125
New York 83
Milan 82
Los Angeles 76
Council Bluffs 60
Santa Clara 59
Seattle 52
Dallas 51
Princeton 44
Fairfield 41
Hanover 39
Ho Chi Minh City 37
Wilmington 37
Woodbridge 34
Ann Arbor 31
Dublin 31
Houston 30
Toronto 29
Shanghai 28
Hanoi 26
Buffalo 25
Cambridge 25
Dearborn 24
Frankfurt am Main 22
Boardman 21
Columbus 21
Guangzhou 20
Helsinki 20
Phoenix 20
Kiez 19
Piscataway 19
Lauterbourg 18
Mountain View 18
Nanjing 18
Jakarta 17
Moscow 17
Taichung 17
Tokyo 17
Munich 16
São Paulo 16
Turin 16
Bengaluru 15
Hangzhou 15
Mumbai 15
North Bergen 15
Nürnberg 15
Des Moines 13
Redwood City 13
Rome 13
Chongqing 12
Jinan 12
Montreal 12
Redmond 12
The Dalles 12
Andover 11
Berlin 11
Grafing 11
Istanbul 11
Tianjin 11
Cairo 10
Guadalajara 10
Ottawa 10
Saint Petersburg 10
Changsha 9
Hefei 9
Naples 9
Shenyang 9
Boise 8
Brooklyn 8
Cangzhou 8
Chicago 8
Groningen 8
Jersey City 8
Nanchang 8
Nuremberg 8
Sakarya 8
Taiyuan 8
Ankara 7
Hebei 7
London 7
Newark 7
Seoul 7
Abidjan 6
Jacksonville 6
Quanzhou 6
Secaucus 6
Tala 6
Atlanta 5
Baltimore 5
Bari 5
Bogotá 5
Bologna 5
Brussels 5
Cagliari 5
Totale 3.337
Nome #
Hepatic Fat-Genetic Risk Score Predicts Hepatocellular Carcinoma in Patients With Cirrhotic HCV Treated With DAAs 765
Maintained long-term suppression of HBV replication in NUC-naïve patients with chronic hepatitis B treated with ETV monotherapy in field practice : the Italian multicenter experience 405
IL28B polymorphisms predict interferon-related hepatitis B surface antigen seroclearance in genotype D hepatitis B e antigen-negative patients with chronic hepatitis B 387
Entecavir monotherapy in 418 NUC-naïve patients with chronic hepatitis B from field practice : high efficacy and favorable safety profile over 3 years of treatment 375
Donor/recipient match of IL28B to predict interferon response in recurrent hepatitis C 311
Interleukin 28B genotype and insulin resistance in chronic hepatitis C patients 285
Hepatitis C virus deletion mutants are found in individuals chronically infected with genotype 1 hepatitis c virus in association with age, high viral load and liver inflammatory activity 282
Limited utility of ITPA deficiency to predict early anemia in HCV patients with advanced fibrosis receiving telaprevir 275
Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis C 272
Transmission of hepatitis G virus in patients with angioedema treated with steam-heated plasma concentrates of C1 inhibitor 257
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting 248
Genome Wide Association Study Identifies Genetic Variants Associated With Early And Sustained Response To (Peg)Interferon In Chronic Hepatitis B Patients: The GIANT-B Study 247
Tenofovir alafenamide as a rescue therapy in a patient with HBV-cirrhosis with a history of Fanconi syndrome and multidrug resistance 237
Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4 237
Genetic variation in the interleukin-28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection 230
Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous daa failure 202
Decompensation in Direct-Acting Antiviral Cured Hepatitis C Virus Compensated Patients With Clinically Significant Portal Hypertension: Too Rare to Warrant Universal Β-Blocker Therapy 198
Incidence of liver- and non-liver-related outcomes in patients with HCV-cirrhosis after SVR 193
Application of EASL 2017 criteria for switching hepatitis B patients from tenofovir disoproxil to entecavir or tenofovir alafenamide 186
Treatment of 320 genotype 3 cirrhotic patients with 12 weeks Sofosbuvir/Velpatasvir with or without ribavirin: real life experience from Italy 186
Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro 168
Safety and efficacy of off-label bulevirtide monotherapy in patients with HDV with decompensated Child-B cirrhosis—A real-world case series 164
Long-term effectiveness, safety, and liver stiffness dynamics of PBC treatment with obeticholic acid in real-world 148
Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection 7
Totale 6.265
Categoria #
all - tutte 15.219
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.219


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022353 0 0 0 43 44 33 33 42 52 44 15 47
2022/2023429 56 62 36 33 30 66 10 45 50 13 18 10
2023/2024361 22 30 29 27 90 23 20 18 25 15 25 37
2024/2025781 26 76 25 79 40 31 39 89 53 93 74 156
2025/20261.993 173 101 176 119 227 123 261 77 138 109 285 204
2026/2027573 233 125 129 86 0 0 0 0 0 0 0 0
Totale 6.265